Archive - October 2024
Merck Acquires Modifi Biosciences
MDMA Therapy for Mental Health Conditions: Do the Benefits Outweigh the Risks?
FDA Approves AbbVie Therapy for Adults with Advanced Parkinson’s Disease
Report: Radiopharmaceutical Market Expected to Reach $26.51 Billion by 2031
AbbVie, Gedeon Richter Ink Deal to Develop Novel Targets for Neuropsychiatric Conditions
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Strengthening Regulatory Framework for Compounded Medications
Regulatory Collaboration on Mpox Treatments Summarized in Report